SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601830-23-000032
Filing Date
2023-05-25
Accepted
2023-05-25 17:29:19
Documents
12
Period of Report
2023-05-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20230525.htm   iXBRL 8-K 29379
  Complete submission text file 0001601830-23-000032.txt   166346

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20230525.xsd EX-101.SCH 1905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20230525_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20230525_pre.xml EX-101.PRE 13045
6 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20230525_htm.xml XML 10606
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 23962133
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences